Summit Therapeutics, Inc. (SMMT)
17.90
+2.05
(+12.93%)
USD |
NASDAQ |
May 20, 16:00
17.89
-0.01
(-0.06%)
After-Hours: 20:00
Summit Therapeutics Market Cap : 13.89B for May 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Revolution Medicines, Inc. | 31.94B |
| BioMarin Pharmaceutical, Inc. | 9.701B |
| Relay Therapeutics, Inc. | 2.494B |
| Alnylam Pharmaceuticals, Inc. | 39.84B |
| Amgen, Inc. | 179.06B |
Market Cap Related Metrics
| PEG Ratio | -0.0290 |
| Price to Book Value | 25.45 |
| Price | 17.90 |
| Earnings Yield | -8.96% |
| PEGY Ratio | -0.0290 |